These results indicate that the observed increase in tumor size when CPT1A is overexpressed is due to differences (such as higher proliferation under hypoxia as shown in Figure 4) that cannot be explained through the utilization of these proliferation and angiogenesis biomarkers. This evidence concerns the gene CPT1A and neoplasm.